Desk›Healthcare› Gufic Biosciences Ltd
Gufic Biosciences Ltd
BSE 509079 · NSE GUFICBIO · ISIN INE742B01025 · Group B · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹411.00
+0.72%
BSE close, 28 August 2026
₹4,121.61 cr
10.0 cr shares · Micro cap
₹1,099.36 cr
as published
56.1× · 7.18×
EPS ₹7.33 · BV ₹57.24
940.48 / 63.15
₹ cr, as filed
26
6 selected · 23%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -8.2% |
|---|---|
| Against 52-week low | +53.6% |
| Day change | +0.72% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹7.33 |
|---|---|
| Price / earnings | 56.07× |
| Price / book | 7.18× |
| Book value — derived, price ÷ P/B | ₹57.24 |
| Return on equity | 12.81% |
| Operating margin | 18.09% |
| Net margin | 8.61% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 12.81%
- ROE as published
- 12.81%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 260.82 | 22.46 | 2.24 | 18.09% | 8.61% |
| Mar-26 · Q | 252.05 | 20.57 | 2.05 | 17.74% | 8.16% |
| FY25-26 | 940.48 | 63.15 | 6.30 | 16.26% | 6.71% |
Quarter on quarter
- Revenue, quarter on quarter
- +3.5%
- Net profit, quarter on quarter
- +9.2%
- Operating margin, quarter on quarter
- +35 bps
Disclosure profile 26 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Change in Directorate | 1 |
| Concall Transcript | 1 |
| Credit Rating | 1 |
| Investor Presentation | 1 |
| Results | 1 |
| Selected sub-total | 6 |
| Procedural | |
| General | 4 |
| AGM / EGM | 3 |
| Newspaper Publication | 3 |
| Analyst / Investor Meet | 2 |
| Annual Report | 1 |
| BRSR | 1 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| Outcome | 1 |
| Record Date | 1 |
| Subsidiary Incorporation | 1 |
| Trading Window | 1 |
| Procedural sub-total | 20 |
| Total | 26 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
26 filings · 6 selected · busiest 2026-08-12 and 2026-08-14
Filing rhythm · the twelve most recent
2026-08-172026-10-06
SelectedProcedural
Filings
26 in the window · 5 earlier on record
-
6 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026 is attached herewith
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
29 September 2026 ·
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is attached herewith
Company Update / General View filing →
-
28 September 2026 ·
Closure of Trading Window
Intimation of closure of Trading Window is attached herewith
Insider Trading / SAST / Closure of Trading Window View filing →
-
28 September 2026 ·
Intimation Of Environmental, Social And Governance ('ESG') Rating
Intimation of Environmental, Social and Governance ('ESG') Rating is attached herewith
Company Update / General View filing →
-
24 September 2026 ·
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is attached herewith
Company Update / General View filing →
-
8 September 2026 ·
Credit Rating
Intimation of Credit Rating is attached herewith
Company Update / Credit Rating View filing →
-
7 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Voting Results and Consolidated Scrutinizer Report of 42nd Annual General Meeting of the Company held on Friday, September 04, 2026 is attached herewith
AGM/EGM / AGM View filing →
-
4 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 42nd Annual General Meeting of the Company held on Friday, September 04, 2026 is attached herewith
AGM/EGM / AGM View filing →
-
2 September 2026 ·
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Promotion And Change In Designation Of Senior Management Personnel
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Promotion and Change in Designation of Senior Management Personnel is attached herewith
Company Update / General View filing →
-
21 August 2026 ·
Earnings Call Transcript
Written Transcript of Earnings Conference Call held on August 17, 2026 at 04:30 p.m. is attached herewith
Company Update / Earnings Call Transcript View filing →
-
18 August 2026 ·
Newspaper Publication
Newspaper advertisement regarding Special Window for re-lodgement of transfer and dematerialization of physical shares is attached herewith
Company Update / Newspaper Publication View filing →
-
17 August 2026 ·
Analyst / Investor Meet - Outcome
Intimation of Audio Recording of Earnings Conference Call held on August 17, 2026 at 04:30 p.m. is attached herewith
Company Update / Analyst / Investor Meet View filing →
-
14 August 2026 ·
Investor Presentation
Investor Presentation for the Quarter ended June 30, 2026 is attached herewith
Company Update / Investor Presentation View filing →
-
14 August 2026 ·
Acquisition
Approval for Inc orporation of Subsidiary in the Philippines and Investment by way of Subscription to its Equity Share Capital is attached herewith.
Company Update / Acquisition View filing →
-
14 August 2026 ·
Results - Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2026
Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2026 is attached herewith.
Result / Financial Results View filing →
-
14 August 2026 ·
Board Meeting Outcome for Meeting Held On Friday, August 14, 2026
Outcome of the Board of Directors Meeting held on Friday, August 14, 2026 is attached herewith.
Board Meeting / Outcome of Board Meeting View filing →
-
13 August 2026 ·
Newspaper Publication
Newspaper Advertisement - Notice of 42nd Annual General Meeting of the Company and evoting details is attached herewith.
Company Update / Newspaper Publication View filing →
-
12 August 2026 ·
Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report for the Financial Year ended March 31, 2026, is attached herewith
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
12 August 2026 ·
Reg. 34 (1) Annual Report.
Annual Report for the Financial Year 2025-2026 alongwith Notice of 42nd Annual General Meeting is attached herewith.
Others / Reg. 34 (1) Annual Report View filing →
-
12 August 2026 ·
Intimation Of Record Date For Final Dividend And 42Nd Annual General Meeting
Intimation for book closure and record date for the purpose of 42nd Annual General Meeting and payment of final dividend for the financial year ended March 31, 2026
Corp. Action / Record Date View filing →
-
12 August 2026 ·
Shareholders Meeting - 42Nd Annual General Meeting Of The Company Scheduled To Be Held On Friday, September 04, 2026
Intimation of 42nd Annual General Meeting, is attached herewith
AGM/EGM / AGM View filing →
-
11 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Earnings Conference Call scheduled to be held on August 17, 2026 is attached herewith
Company Update / Analyst / Investor Meet View filing →
-
10 August 2026 ·
Board Meeting Intimation for Consideration And Approval Of, Inter Alia, Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30, 2026
Gufic Biosciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
Board Meeting / Board Meeting View filing →
-
7 August 2026 ·
Newspaper Publication
Newspaper Advertisement - Notice of the 42nd Annual General Meeting of the Company is attached herewith
Company Update / Newspaper Publication View filing →
-
31 July 2026 ·
Change in Directorate
Intimation for Re-appointment of Mr. Pankaj Jayakumar Gandhi (DIN: 00001858) as the Whole Time Director of the Company is attached herewith.
Company Update / Change in Directorate View filing →
-
31 July 2026 ·
Board Meeting Outcome for Meeting Held On Friday, July 31, 2026
Outcome of the Board of Directors Meeting held on Friday, July 31, 2026 is attached herewith
Others / Outcome without intimation View filing →
RSS feed for Gufic Biosciences Ltd · the 50 most recent filings